.png){kind=logo}
GC Asia
Glaxo drinks deep with $9bn bond as US brims with cash
It was another $30bn week in the all-guns-blazing US investment grade bond market, but the clear star of the show was the $9bn four tranche offering for UK pharmaceutical firm GlaxoSmithKline, which pulled a staggering $17.8bn of orders.
 |
Launched to fund a share buyback programme, the deal broke several US dollar high grade records.It was the largest corporate Yankee issue since British Telecom in 2000; the biggest corporate bond since WorldCom in 2001; and the largest ever corporate issue outside the telecom ...
Already a subscriber? Login
-
Latest news from Corporate Bonds
-
Dollar bond market breaks out in green spots
06 May 2021 -
SLBs to surge though role still needs defining
06 May 2021 -
IG corp buyers show preference for ESG and short maturities
06 May 2021 -
Attractive arb for Deutsche Bahn 12 year Swissie
06 May 2021 -
LimakPort lining up dollar bond as Turkey holds rates steady
06 May 2021
-
-
Latest news from Corporate Bonds
-
Dollar bond market breaks out in green spots
06 May 2021 -
SLBs to surge though role still needs defining
06 May 2021 -
IG corp buyers show preference for ESG and short maturities
06 May 2021 -
Attractive arb for Deutsche Bahn 12 year Swissie
06 May 2021 -
LimakPort lining up dollar bond as Turkey holds rates steady
06 May 2021
-
